End-to-End Statistical Expertise for Every Stage of Your Trial

From study design to NDA submission, Hill Research delivers full-service biostatistics and programming solutions that ensure accuracy, compliance, and regulatory success.

Request a Proposal

Next-Level Biostatistics Support

Hill Research provides project-based biostatistics and statistical programming services designed to accelerate your clinical development programs.
Our cross-functional teams of biostatisticians, programmers, and medical writers deliver inspection-ready outputs — from protocol design and SAP development to FDA and EMA submissions

With proven experience in NDA, BLA, and IND filings, we ensure your deliverables meet the highest scientific and regulatory standards, empowering you to move from data to decision with confidence.

What We Deliver

  • Protocol development, randomization schedules, and sample size determination.

  • Comprehensive design and implementation aligned with clinical objectives.

  • SDTM and ADaM dataset generation, Define.xml, and eCRT packages.

  • Support for DMC/DSMB activities, safety summaries, and efficacy evaluations.

  • Integrated collaboration across biostatistics and scientific communications teams.

Download Now

Why Sponsors Choose Hill Research

  • Regulatory Precision

    Our deliverables meet FDA/EMA expectations and are BIMO inspection-ready

  • Unmatched Data Integrity

    Independent QC, Pinnacle 21 validation, and traceability across all datasets.

  • Collaborative Delivery

    Seamless communication among statisticians, programmers, and medical writers.

  • Proven Track Record

    Trusted by 10+ top global pharma companies to ensure compliant, high-quality submissions.

Our project-based CRO model combines the depth of traditional statistical services with modern automation and AI-assisted validation.


This hybrid approach ensures faster turnaround, reduced cost, and uncompromised quality — allowing sponsors to achieve regulatory milestones with confidence and precision.

Know More

Impact That Matters

  • End-to-End Expertise

    One partner from protocol to FDA submission.

  • Reduced Review Cycles

    Prevalidated datasets minimize back-and-forth with regulators.

  • High-Quality Insights

    Statistical rigor that supports data-driven decisions and publication impact.

Experience Now